Search research articles
Contact Us
Filters
Showing results (61-70 of 499) with videos related to
Page
of 50
Sort By:
European Journal of Gastroenterology & Hepatology
|
June 16, 2004
Systemic treatment of pancreatic cancer
Eric Van Cutsem, Raymond Aerts, Karin Haustermans, et al.
Cancers
|
June 8, 2017
Improving Outcomes in Patients with CRC: The Role of Patient Reported Outcomes-An ESDO Report
Eric Van Cutsem, Aimery De Gramont, Geoffrey Henning, et al.
Nature Reviews. Clinical Oncology
|
July 29, 2009
Implications for KRAS status and EGFR-targeted therapies in metastatic CRC
Nicola Normanno, Sabine Tejpar, Floriana Morgillo, et al.
Targeted Oncology
|
April 30, 2013
An analysis of the treatment effect of panitumumab on overall survival from a phase 3, randomized, controlled, multicenter trial (20020408) in patients with chemotherapy refractory metastatic colorectal cancer
Melanie Poulin-Costello, Laurent Azoulay, Eric Van Cutsem, et al.
British Journal of Clinical Pharmacology
|
May 12, 2023
Pharmacokinetic drug-drug interactions with direct anticoagulants in the management of cancer-associated thrombosis
Lorenz Van der Linden, Thomas Vanassche, Eric Van Cutsem, et al.
European Journal of Gastroenterology & Hepatology
|
February 10, 2011
European initiatives in colorectal cancer screening
Colm A O'Morain, Eric Van Cutsem, Julius Spicak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 18, 2013
Use of early tumor shrinkage to predict long-term outcome in metastatic colorectal cancer treated with cetuximab
Hubert Piessevaux, Marc Buyse, Michael Schlichting, et al.
The Oncologist
|
May 14, 2014
Optimizing treatment outcomes with regorafenib: personalized dosing and other strategies to support patient care
Axel Grothey, Suzanne George, Eric van Cutsem, et al.
The Journal of Pain
|
February 1, 2025
Increased TRPA1 functionality in the skin of rats and cancer patients following oxaliplatin treatment
Heleen Marynissen, Sílvia Pinto, Nele Van Ranst, et al.
Targeted Oncology
|
June 2, 2011
Uptake of KRAS mutation testing in patients with metastatic colorectal cancer in Europe, Latin America and Asia
Fortunato Ciardiello, Sabine Tejpar, Nicola Normanno, et al.
Page
of 50
Search research articles
Search
Showing results (61-70 of 499) with videos related to
Sort By:
Page
of 50
European Journal of Gastroenterology & Hepatology
|
June 16, 2004
Systemic treatment of pancreatic cancer
Eric Van Cutsem, Raymond Aerts, Karin Haustermans, et al.
Cancers
|
June 8, 2017
Improving Outcomes in Patients with CRC: The Role of Patient Reported Outcomes-An ESDO Report
Eric Van Cutsem, Aimery De Gramont, Geoffrey Henning, et al.
Nature Reviews. Clinical Oncology
|
July 29, 2009
Implications for KRAS status and EGFR-targeted therapies in metastatic CRC
Nicola Normanno, Sabine Tejpar, Floriana Morgillo, et al.
Targeted Oncology
|
April 30, 2013
An analysis of the treatment effect of panitumumab on overall survival from a phase 3, randomized, controlled, multicenter trial (20020408) in patients with chemotherapy refractory metastatic colorectal cancer
Melanie Poulin-Costello, Laurent Azoulay, Eric Van Cutsem, et al.
British Journal of Clinical Pharmacology
|
May 12, 2023
Pharmacokinetic drug-drug interactions with direct anticoagulants in the management of cancer-associated thrombosis
Lorenz Van der Linden, Thomas Vanassche, Eric Van Cutsem, et al.
European Journal of Gastroenterology & Hepatology
|
February 10, 2011
European initiatives in colorectal cancer screening
Colm A O'Morain, Eric Van Cutsem, Julius Spicak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 18, 2013
Use of early tumor shrinkage to predict long-term outcome in metastatic colorectal cancer treated with cetuximab
Hubert Piessevaux, Marc Buyse, Michael Schlichting, et al.
The Oncologist
|
May 14, 2014
Optimizing treatment outcomes with regorafenib: personalized dosing and other strategies to support patient care
Axel Grothey, Suzanne George, Eric van Cutsem, et al.
The Journal of Pain
|
February 1, 2025
Increased TRPA1 functionality in the skin of rats and cancer patients following oxaliplatin treatment
Heleen Marynissen, Sílvia Pinto, Nele Van Ranst, et al.
Targeted Oncology
|
June 2, 2011
Uptake of KRAS mutation testing in patients with metastatic colorectal cancer in Europe, Latin America and Asia
Fortunato Ciardiello, Sabine Tejpar, Nicola Normanno, et al.
Page
of 50